Jun 3, 2026 10:13PM
Jun 3, 2026 10:13PM
Jun 3, 2026 07:19AM
Jun 3, 2026 07:19AM
Jun 2, 2026 08:26AM
Jun 2, 2026 08:25AM
Jun 2, 2026 08:11AM Celcuity reports positive Phase 3 trial results for gedatolisib in breast cancer
May 18, 2026 07:05AM
May 14, 2026 04:01PM
May 14, 2026 07:30AM
May 14, 2026 07:30AM
May 1, 2026 05:03PM
May 1, 2026 05:03PM
Mar 25, 2026 04:01PM Celcuity Inc. Reports Release of Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 9, 2026 05:42PM
Mar 9, 2026 05:42PM
Feb 12, 2026 04:05PM
Feb 12, 2026 04:05PM
Jan 20, 2026 07:30AM
Jan 20, 2026 07:30AM
Jan 8, 2026 12:08PM The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
Dec 11, 2025 02:35PM
Dec 11, 2025 02:35PM
Nov 17, 2025 04:05PM
Nov 12, 2025 04:01PM
Oct 18, 2025 04:30AM
Oct 18, 2025 04:30AM
Sep 9, 2025 04:01PM Celcuity increases term loan facility to $500 million
Sep 9, 2025 04:01PM
Aug 27, 2025 04:05PM
Aug 18, 2025 06:47AM
Aug 14, 2025 04:01PM
Jul 28, 2025 07:00AM
Jul 28, 2025 07:00AM
Dec 11, 2024 07:05AM Celcuity (CELC) Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy
Dec 11, 2024 07:05AM
May 30, 2024 02:29PM
May 30, 2024 07:05AM
May 30, 2024 07:00AM
Nov 13, 2023 07:05AM
Aug 22, 2023 04:01PM
Mar 23, 2023 04:00PM Celcuity Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Dec 7, 2022 04:00PM
Nov 10, 2022 04:00PM
Aug 11, 2022 04:00PM
Jul 18, 2022 05:12PM
Jul 18, 2022 05:10PM
May 16, 2022 04:00PM
Mar 23, 2022 04:00PM Celcuity Inc. Reports Fourth Quarter and Full Year 2021 Financial Results, Pivotal Phase 3 Trial Design for Gedatolisib in the Treatment of Advanced Breast Cancer, and Business Updates
Jan 18, 2022 07:31AM

322,993 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All